Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

Sarah P. Hammond, MD (she/her/hers)

Director of Hematology/Oncology Infectious Diseases
Massachusetts General Hospital
Boston, MA, United States

Sarah Hammond, MD is an assistant professor at Harvard Medical School in Medicine and is part of the clinical faculty in the Infectious Diseases and Hematology/Oncology Divisions at Massachusetts General Hospital where she is the Director of Hematology/Oncology Infectious Diseases and a consulting physician at the Dana-Farber Cancer Institute both in Boston, Massachusetts, USA. Her clinical research is focused on the prevention and treatment of invasive fungal infections in the high-risk cancer and transplant population and in infectious complications of novel immunomodulatory therapies in patients with hematologic malignancy.

Disclosure(s): Cidara: Grant/Research Support; F2G: Grant/Research Support; GSK: Grant/Research Support; Melinta: Advisor/Consultant; Mundipharma: Grant/Research Support; Pfizer: Advisor/Consultant; Roche: Advisor/Consultant; Scynexis: Grant/Research Support; Seres Therapeutics: Advisor/Consultant; Takeda: Advisor/Consultant; Treeline Biotherapeutics: Advisor/Consultant

Presentation(s):